Related references
Note: Only part of the references are listed.Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19
Masaya Sugiyama et al.
GENE (2021)
Acute exacerbations of fibrotic interstitial lung diseases
Atsushi Suzuki et al.
RESPIROLOGY (2020)
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis A Randomized, Double-Blind Placebo-controlled Trial
Yasuhiro Kondoh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Spectrum of Fibrotic Lung Diseases
Marlies Wijsenbeek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias
Toru Arai et al.
RESPIROLOGY (2019)
Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody
Toshinori Takada et al.
RESPIRATORY MEDICINE (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis
Harold R. Collard et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation
Shosaku Nomura et al.
TRANSPLANT IMMUNOLOGY (2017)
Fibrocytes Ameliorate Acute Lung Injury by Decreasing Inflammatory Cytokine and Chemokine Levels and Reducing Neutrophil Accumulation in the Lung
Wenlin Tai et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report
Harold R. Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia
Toru Arai et al.
RESPIROLOGY (2016)
IL-13 is a therapeutic target in radiation lung injury
Su I. Chung et al.
SCIENTIFIC REPORTS (2016)
Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Kensuke Kataoka et al.
CHEST (2015)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Chemokines in tissue fibrosis
Hacer Sahin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome
D. Kudo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis
Keiji Oishi et al.
CYTOKINE (2013)
The C-C motif chemokine ligands CCL5, CCL11, and CCL24 induce the migration of circulating fibrocytes from patients with severe asthma
M. Isgro et al.
MUCOSAL IMMUNOLOGY (2013)
Thrombomodulin: A Bifunctional Modulator of Inflammation and Coagulation in Sepsis
Takayuki Okamoto et al.
CRITICAL CARE RESEARCH AND PRACTICE (2012)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis
Harold R. Collard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Pirfenidone in idiopathic pulmonary fibrosis
H. Taniguchi et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Antje Moeller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Kazuhisa Konishi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis
Robert M. Strieter et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
Yurika Yogo et al.
RESPIRATORY RESEARCH (2009)
Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis
Masanori Akira et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Profibrotic effect of IL-9 overexpression in a model of airway remodeling
Sybille van den Brle et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21
E. M. Pierce et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial
H. Saito et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-β in the lung
K. Nakagome et al.
THORAX (2006)
Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice
N Hamada et al.
JOURNAL OF IMMUNOLOGY (2005)
Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo
D Spight et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients
S Gando et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2005)
Interleukin-7 and transforming growth factor-β play counter-regulatory roles in protein kinase C-δ-dependent control of fibroblast collagen synthesis in pulmonary fibrosis
L Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice
V Barbarin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
BR Celli et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
High-BAL fluid concentrations of RANTES in nonspecific interstitial pneumonia compared with usual interstitial pneumonia
S Yoshioka et al.
RESPIRATORY MEDICINE (2004)
Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10
AM Tager et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
The role of the Th2CC chemokine ligand CCL17 in pulmonary fibrosis
JA Belperio et al.
JOURNAL OF IMMUNOLOGY (2004)
Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model
M Arras et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
KGF regulates pulmonary epithelial proliferation and surfactant protein gene expression in adult rat lung
T Yano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)
GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism
BB Moore et al.
JOURNAL OF IMMUNOLOGY (2000)
Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo
T Arai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)
Share Paper
